D-0912-2023 Class II Terminated

Recalled by L. Perrigo Company — Allegan, MI

FDA drug recall D-0912-2023 was initiated by L. Perrigo Company on Feb 9, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 11, 2023). Affected quantity: 44,280 cartons.

Recall Details

Product Type
Drugs
Report Date
Jul 19, 2023
Initiation Date
Feb 9, 2023
Termination Date
Sep 11, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44,280 cartons

Product Description

Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 36800-691-39), b)45-count cartons (NDC 36800-691-95), and 90-count cartons (NDC 36800-691-75), Distributed by: Topco Associates LLC, Elk Grove Village, IL 60007.

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Nationwide within the USA

Code Information

Lot #: a) 2FV1948, 2ER0285, 2ER0411, Exp. Date 01/24 b)2CR0653, Exp. Date 12/23 c)2GR0331, Exp. Date 04/24

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0912-2023
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0912-2023. Report a data issue: hello@regdatalab.com.